Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Anuj J. Kapadia, who heads the Advanced Computing Methods for Health Sciences Section at ORNL, has been elected as president of the Southeastern Chapter of the American Association of Physicists in Medicine.
Gina Tourassi, associate laboratory director for computing and computational sciences at the US Department of Energy’s (DOE’s) Oak Ridge National Laboratory, has been named a fellow of the Institute of Electrical and Electronics Engineers, the world’s largest organization for technical professionals.
Corning uses neutron scattering to study the stability of different types of glass. Recently, researchers for the company have found that understanding the stability of the rings of atoms in glass materials can help predict the performance of glass products.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Oak Ridge National Laboratory researchers have developed a new family of cathodes with the potential to replace the costly cobalt-based cathodes typically found in today’s lithium-ion batteries that power electric vehicles and consumer electronics.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Paul J. Hanson, ORNL Corporate Fellow, has been elected to the 2020 Class of Fellows of the American Geophysical Union.
David Kropaczek, director of the Consortium for Advanced Simulation of Light Water Reactors, or CASL, at the Department of Energy’s Oak Ridge National Laboratory, has been named a fellow of the American Nuclear Society.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.